Key facts and Forecast
Financial results of Q3 2023
- Strong organic performance of Healthcare partly compensates for market weakness in Life Science and Electronics
- Net sales decrease organically by 4.1% to € 5.2 billion
- EBITDA pre down organically by 13.2% to € 1.4 billion despite double-digit organic earnings growth of Healthcare
- Negative foreign exchange impact increases again over Q2 2023
Forecast
- Company confirms and specifies forecast for fiscal 2023
- Return to organic sales growth expected in 2024
OVERVIEW: BUSINESS PERFORMANCE IN Q3 2023
| Q3 2023 (in € billion) | Change (in %, compared to Q3 2022) | Organic growth (in %, compared to Q3 2022) | |
|---|---|---|---|
| Group net sales | 5.2 | -10.9 | -4.1 |
| EBITDA pre | 1.4 | ‑20.2 | ‑13.2 |
| Life Science sales | 2.2 | -18.3 | -13.2 |
| Healthcare sales | 2.1 | -1.1 | 7.4 |
| Electronics sales | 0.9 | ‑11.6 | ‑4.0 |
We remain disciplined and on track to achieve not only our fiscal 2023 but also our medium-term targets. In 2024, we expect to return to organic sales growth.
Results & Beyond: Our CFO Speaks
Our CFO Helene von Roeder comments on the Q3 2023 results.
-
![Brochure title]()
Quarterly Statement Q3 2023
Download (PDF)Detailed information about the development of our business in the third quarter of 2023.
ADDITIONAL INFORMATION
Downloads for the Media
Additional Downloads
- Presentation for Analysts (PDF)
- Financial Statement (XLS)
- Financial Statement (PDF)
- Regional Sector Sales (XLS)
- Summary (PDF)
Conference call for analysts
- Conference call for analysts
The conference call for analysts can be followed live via webcast at 2 p.m. (CET)
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Confirms Forecast for Fiscal 2023 Despite Difficult ...
In the third quarter of 2023, Merck KGaA, Darmstadt, Germany, once again benefited from its diversified set-up.
2023/11/09
Annual Reports Archive
Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more
Upcoming Events
View All EventsOur Q4 2023 results will be published on March 7, 2024, at 7 a.m. (CET). Our press conference will take place at 10:00 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price